WO2005000007A2 - Methodes de production de plantes qui presentent une meilleure resistance aux maladies - Google Patents

Methodes de production de plantes qui presentent une meilleure resistance aux maladies Download PDF

Info

Publication number
WO2005000007A2
WO2005000007A2 PCT/US2004/017029 US2004017029W WO2005000007A2 WO 2005000007 A2 WO2005000007 A2 WO 2005000007A2 US 2004017029 W US2004017029 W US 2004017029W WO 2005000007 A2 WO2005000007 A2 WO 2005000007A2
Authority
WO
WIPO (PCT)
Prior art keywords
plant
nucleic acid
fad2
plants
regulatory element
Prior art date
Application number
PCT/US2004/017029
Other languages
English (en)
Other versions
WO2005000007A3 (fr
Inventor
Basil S. Shorrosh
Sonia Hallier
Original Assignee
Cargill, Incorporated
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cargill, Incorporated filed Critical Cargill, Incorporated
Priority to CA002530566A priority Critical patent/CA2530566A1/fr
Priority to AU2004251638A priority patent/AU2004251638A1/en
Priority to EP04753784A priority patent/EP1633867A4/fr
Publication of WO2005000007A2 publication Critical patent/WO2005000007A2/fr
Publication of WO2005000007A3 publication Critical patent/WO2005000007A3/fr
Priority to AU2010202889A priority patent/AU2010202889A1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
    • C12N15/8241—Phenotypically and genetically modified plants via recombinant DNA technology
    • C12N15/8261—Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield
    • C12N15/8271—Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield for stress resistance, e.g. heavy metal resistance
    • C12N15/8279—Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield for stress resistance, e.g. heavy metal resistance for biotic stress resistance, pathogen resistance, disease resistance
    • C12N15/8282—Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield for stress resistance, e.g. heavy metal resistance for biotic stress resistance, pathogen resistance, disease resistance for fungal resistance
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
    • C12N15/8241—Phenotypically and genetically modified plants via recombinant DNA technology
    • C12N15/8242—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits
    • C12N15/8243—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits involving biosynthetic or metabolic pathways, i.e. metabolic engineering, e.g. nicotine, caffeine
    • C12N15/8247—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits involving biosynthetic or metabolic pathways, i.e. metabolic engineering, e.g. nicotine, caffeine involving modified lipid metabolism, e.g. seed oil composition

Definitions

  • This invention relates to fungal resistance in plants, and more particularly to methods of making plants that exhibit enhanced resistance to fungal infections.
  • BACKGROUND Fungal diseases are responsible for damage to many cultivated species. The amount of damage varies each year, depending on temperature, amount of rain, and quantity of inoculum present in fields. In some instances, fungal diseases can completely destroy fields, leading to an estimated average loss of yield of 20% of crops worldwide. Blackleg, one of the predominant fungal diseases in rape plants, typically results in losses of tens of millions of dollars annually. Sclerotinia, another predominant fungal disease of Cruciferae plants, which includes Brassica plants as well as 400 other species of plants including Compositae plants such as sunflower and leguminous plants such as pea, also can result in significant economic losses.
  • Blackleg disease is caused by an Ascomycetes fungus whose perfect or sexual form is known as Leptosphaeria maculans and whose imperfect or asexual form is known as Phoma lingam.
  • the sexual form provides the primary inoculum each year and is responsible for the high variability of the fungus.
  • L. maculans is in fact a complex of species, of which two main groups have been identified, TOX + and TOX°.
  • the TOX + species is aggressive and produces two toxins, sirodesmin and phomalide.
  • several strains or pathogenicity groups (PG) exist. In Europe, Australia, and Eastern Canada, PG3 and PG4 are the predominant strains of L.
  • PG2 is the predominant strain of L. maculans.
  • Ascospores on infested canola stubble are the main source of infection by the virulent (i.e., TOX + ) L. maculans.
  • Ascospores are released into the air and can infect cotyledons and younger leaves of plant seedling via stomata or wounds. The initial infection is biotrophic, but then becomes necrotrophic and produces asexual bodies (pycnidia) in the dead tissue.
  • the spores produced from the pycnidia bodies, called pycnidiospores are believed to spread and infect other leaves of neighboring plants after being released by rain splash or other mechanical stress.
  • Sclerotinia sclerotiorum an Ascomycetes fungus, produces white rot on the plants it infects.
  • S. sclerotiorum has broad ecological distribution, but is most common in temperate regions.
  • S. sclerotiorum produces a fluffy white mass of mycelia on the surface of the host and on adjacent soil surfaces. Dense white bodies start forming within the mycelia, which becomes black and hard as the fungus matures.
  • the hardened mycelia are called sclerotia, which allow the fungus to survive for several years in soil.
  • the sclerotia will germinate, and produce either mycelium, which can infect plants that are in direct contact with the sclerotia, or spore-producing apothecia.
  • Most infections in canola result from air-borne spores produced by apothecia at the soil surface. Spores often infect, germinate, and grow in petals and eventually fall on other plant tissue.
  • the fungus eventually leads to leaf, stem, and -fruit rot. In the stem, the fungus will form new sclerotia, which fall to the soil at harvest, thereby completing the disease cycle.
  • prophylactic measures such as crop rotations or burying of crop debris, fungicide use, and genetic improvement.
  • Prophylactic measures are not very effective as fungi can survive for many years in the soil.
  • Fungicides can be effective when applied at the appropriate time, but cost often is high compared with any gain in yield.
  • genetic improvement in plants for resistance to S. sclerotiorum has been limited since only plant species that exhibit low tolerance to the fungus have been identified. Thus, a need exists for plants that are resistant to such fungi, as well as for methods of improving plant resistance to fungi.
  • the invention is based on the surprising discovery that decreasing expression of the gene encoding delta 12 fatty acid desaturase (fad2) or omega 6 fatty acid desaturase (fad ⁇ ) in plants provides such plants with a significantly enhanced ability to resist infection by L. maculans and/or S. sclerotiorum compared with existing natural resistance.
  • Expression of fad2 or fad ⁇ can be decreased such that Fad2 or Fad6 proteins, respectively, are reduced at particular locations (e.g., the leaves), at a particular stage of development, or upon stimulation by the appropriate environmental conditions.
  • the invention provides a method for producing a dicotyledonous plant.
  • Such a method includes introducing a nucleic acid construct into cells of a plant, wherein the nucleic acid construct comprises a regulatory element operably linked to a delta- 12 fatty acid desaturase (fad2) nucleic acid molecule; generating one or more progeny plants from the cells; and identifying at least one of the progeny plants that exhibits enhanced resistance to Sclerotinia sclerotiorum relative to a corresponding control plant.
  • Representative plants include Brassica plants, Helianthus annuus plants, and Glycine max plants. Methods of the invention also can be used to make hybrid plants (e.g., Brassica or Helianthus annuus hybrid plants).
  • the regulatory element is a promoter such as a cruciferin promoter and/or a constitutive promoter.
  • the fad2 nucleic acid molecule includes both fad2F and fad2D nucleic acid sequences.
  • the fad2 nucleic acid molecule is operably linked to the regulatory element in sense orientation. Such a molecule can result in co-suppression of fad2 nucleic acid sequences in the plant.
  • a construct for use in the methods of the invention can encode a self-splicing ribozyme such as the negative strand of the satellite RNA from Barley Yellow Dwarf Virus operably linked to the fad2 nucleic acid molecule.
  • the fad2 nucleic acid molecule is operably linked to the regulatory element in antisense orientation.
  • the fad2 nucleic acid molecule comprises fad2 nucleic acid sequences in sense orientation operably linked to fad2 nucleic acid sequences in antisense orientation, wherein the fad2 nucleic acid sequences in sense orientation and the fad2 nucleic acid sequences in antisense orientation are on the same strand, wherein the fad2 nucleic acid sequences in sense orientation and the fad2 nucleic acid sequences in antisense orientation are complementary.
  • Such a construct can further include a spacer nucleic acid sequence, wherein the spacer nucleic acid sequences operably link the fad2 nucleic acid sequences in sense orientation and the fad2 nucleic acid sequences in antisense orientation, wherein the spacer nucleic acid sequences are between the fad2 nucleic acid sequences in sense orientation and the fad2 nucleic acid sequences in antisense orientation.
  • a plant made by a method of the invention produces seeds that exhibit an altered oleic acid to linoleic acid ratio relative to seeds produced by the corresponding control plant. It is desirable that leaves of the plant exhibit an altered oleic acid to linoleic acid ratio relative to leaves from the corresponding control plant.
  • Methods of the invention can further include producing a plant line from one or more of the progeny plants. Methods of the invention also can include contacting the progeny plants with a compound selected from the group consisting of salicylic acid
  • the nucleic acid construct further comprises a regulatory element operably linked to a nucleic acid molecule encoding a KASII polypeptide, a nucleic acid molecule encoding a thioesterase polypeptide, or a regulatory element operably linked to a nucleic acid molecule encoding an omega 6 fatty acid desaturase (fad ⁇ ).
  • the methods of the invention further include introducing a second nucleic acid construct into the cells, wherein the second nucleic acid construct comprises a regulatory element operably linked to a nucleic acid molecule encoding a polypeptide selected from the group consisting of thioesterase, 3-ketoacyl synthase II (KASII), chitinase, ⁇ -l,3-glucanase, PR5, and PRl.
  • the invention provides a method for producing a Brassica plant.
  • Such a method includes introducing a nucleic acid construct into Brassica cells, wherein the nucleic acid construct comprises a regulatory element operably linked to a delta- 12 fatty acid desaturase (fad2) nucleic acid molecule; generating one or more progeny plants from the cells; and identifying at least one of the progeny plants that exhibits enhanced resistance to Sclerotinia sclerotiorum and/or Leptosphaeria maculans relative to a corresponding control plant.
  • the invention provides a method for producing a Brassica plant.
  • Such a method includes providing plant cells comprising a mutation in a fad2 and/or fad ⁇ nucleic acid; generating one or more progeny plants from the cells; and identifying at least one of the progeny plants that exhibits enhanced resistance to Sclerotinia sclerotiorum and/or Leptosphaeria maculans relative to a corresponding control plant.
  • the invention provides a method for producing a Brassica plant.
  • Such a method includes introducing a nucleic acid construct into Brassica cells, wherein the nucleic acid construct comprises a regulatory element operably linked to an omega 6 fatty acid desaturase (fad ⁇ ) nucleic acid molecule; generating one or more progeny plants from the cells; and identifying at least one of the progeny plants that exhibits enhanced resistance to Sclerotinia sclerotiorum and/or Leptosphaeria maculans relative to a corresponding control plant.
  • the invention also features a transgenic plant comprising a nucleic acid construct.
  • the construct comprises a regulatory element operably linked to an omega 6 fatty acid desaturase nucleic acid.
  • the regulatory element confers expression in at least one vegetative tissue of the plant, and the plant has enhanced resistance to S. sclerotiorum and/or L. maculans in at least that tissue, relative to the corresponding resistance in that tissue of a corresponding control plant.
  • the plant can have enhanced resistance to S. sclerotiorum and the regulatory element can confer expression in leaf tissue.
  • the plant can be a Brassica plant, e.g., a Brassica napus plant.
  • the plant can have enhanced resistance to L. maculans and the regulatory element can confer expression in stem tissue.
  • the invention also features a transgenic plant comprising a nucleic acid construct.
  • the construct comprises a regulatory element operably linked to a delta- 12 fatty acid desaturase nucleic acid, and the regulatory element confers expression in at least one vegetative tissue of the plant.
  • the plant has enhanced resistance to S. sclerotiorum and/or L. maculans in at least that tissue, relative to the corresponding resistance in that tissue of a corresponding control plant.
  • the plant can have enhanced resistance to S. sclerotiorum and the regulatory element can confer expression in leaf tissue.
  • the plant can be a Brassica plant, e.g., a Brassica napus plant.
  • the plant can have enhanced resistance to L. maculans and the regulatory element can confer expression in stem tissue.
  • the invention provides a method for producing a Brassica plant.
  • Such a method includes increasing the ratio of oleic acid to linoleic acid in Brassica cells; generating one or more progeny plants from the cells; and identifying at least one of the progeny plants that exhibits enhanced resistance to Sclerotinia sclerotiorum and/or Leptosphaeria maculans.
  • the oleic acid and the linoleic acid can be cytosolic or chloroplastic.
  • the invention provides the use of a nucleic acid construct comprising a regulatory element operably linked to a fad2 and/or fad ⁇ nucleic acid molecule for the enhanced resistance in a plant to S. sclerotiorum or L. maculans.
  • the regulatory element can be a promoter, for example, a cruciferin promoter.
  • the fad2 and/or fad ⁇ nucleic acids are in sense orientation; in other embodiments, the fad2 and/or fad6 nucleic acids are in antisense orientation.
  • all technical and scientific terms used herein have the same meaning as commonly understood by one of ordinary skill in the art to which this invention belongs. Although methods and materials similar or equivalent to those described herein can be used to practice the invention, suitable methods and materials are described below. All publications, patent applications, patents, and other references mentioned herein are incorporated by reference in their entirety, h case of conflict, the present specification, including definitions, will control.
  • FIG. 1 is a schematic of the pMB119 construct containing fad2.
  • the invention features methods of making plants that exhibit enhanced resistance to fungi, in particular, to S. sclerotiorum and L. maculans.
  • Plants and plant lines made using methods of the invention exhibit an altered ratio of oleic acid (18:1) to linoleic acid (18:2), which can be achieved, for example, by decreasing the expression of the enzymes involved in the conversion of 18:1 to 18:2 such as fad2 and/or fad ⁇ .
  • Fad2 is also known as omega-6 fatty acid desaturase, cytoplasmic oleic desaturase, or oleate desaturase.
  • Fad2 catalyzes the desaturation of cytosolic oleic acid (18:1) to linoleic acid (18:2). Desaturation refers to the removal of two hydrogen atoms from a molecule, resulting in the formation of a carbon-carbon double bond, and generally occurs in plastids and in the endoplasmic reticulum. Specifically, Fad2 catalyzes the formation of a double bond between carbon positions 6 and 7 (numbered from the methyl end), i.e., carbons that correspond to positions 12 and 13 (numbered from the carbonyl carbon) of an 18 carbon-long fatty acyl chain.
  • a microsomal fad2 has been cloned and characterized (see, for example, Okuley et al., 1994, Plant Cell, 6:147-58).
  • the nucleotide sequences of higher plant genes encoding microsomal fad2 and mutants thereof are described in U.S. Patent Nos. 6,372,965 and 6,342,658.
  • Fad2D two major isoforms of Fad2 have been characterized, Fad2D and
  • Fad2F Brassica plants having a point mutation in fad2D (e.g., IMC129) exhibit increased oleic acid content in the seeds, but not in the roots or leaves. Such plants do not show any morphological abnormalities.
  • Brassica plants containing a point mutation in both fad2D and fad2F e.g., B. napus lines Q508 and 5Q4275
  • Omega-6 fatty acid desaturase (fad6) is the chloroplastic fad2. Fad6 catalyzes the desaturation of chloroplast 16:1 and 18:1 to 16:2 and 18:2, respectively.
  • Fad6 Plants deficient in Fad6 have increased levels of monounsaturated fatty acids and are deficient in trienoic fatty acids. Plants carrying a mutation in fad6 are characterized, at low temperatures, by leaf chlorosis, a reduced growth rate, and changes in chloroplast morphology such as a decrease in size and appressed regions of thylakoid membranes. Fad6 is thought to be a transmembrane protein. See, for example, Hitz et al., 1994, Plant Physiol, 105:635-641 and GenBank Accession Nos. AF229391, AF229392, and X78311.
  • genes encoding products involved in fatty acid synthesis or host defense can be manipulated to further enhance the observed disease resistance.
  • Genes encoding products involved in fatty acid synthesis include, for example, 3-ketoacyl synthase II (KASII), and thioesterase.
  • Representative host defense genes include, but are not limited to, those encoding chitinase, ⁇ -l,3-glucanase, PR5 (e.g., osmotin or osmotin-like proteins such as AP24), and PR1. See, for example, PCT Publication No. WO 02/061043.
  • Additional host defense genes that can be used in the methods of the invention include those that encode peroxidases, ribosome inactivating proteins, protease inhibitors, defensins, thionins, ribonucleases, polygalacturonase inhibitor proteins, lipid transfer proteins, glycine-rich proteins, and extensin or hydroxyproline rich proteins.
  • 3-ketoacyl synthase II (KASII) is involved in the biosynthesis of saturated fatty acids in plant chloroplasts.
  • C2 units from acyl thioesters are linked sequentially, beginning with the condensation of acetyl Co-enzyme A (CoA) and malonyl-acyl carrier protein (malonyl-ACP) to form a C4 acyl fatty acid.
  • This condensation reaction is catalyzed by a 3-ketoacyl synthase III (KASIII).
  • KASI 3-ketoacyl synthase I
  • C4 to C14 fatty acyl moiety
  • malonyl-ACP malonyl-ACP
  • 3-ketoacyl moieties are also referred to as ⁇ -ketoacyl moieties.
  • Representative -KASII sequences include those shown in GenBank Accession Nos. AF026149 andU39441, and in Domergue & Post-Beittenmiller, 2000, Biochem. Soc. Trans. , 28:610-3.
  • a group of enzymes that may regulate the characteristics of plant lipids are the acyl-CoA thioesterases (ACHs). Thioesterases hydrolyze an ester bond in long chain fatty acyl-CoAs, yielding free fatty acid and CoA.
  • thioesterases can thus influence intracellular levels of free fatty acids and their CoA esters.
  • a thioesterase enzyme hydrolyzes the fatty acyl group, thereby forming free palmitate (palmitoyl-ACP + H 2 O - ⁇ palmitate + ACP-SH).
  • the sequences of representative thioesterases can be found, for example, in GenBank Accession Nos. X87842 and AJ488493, as well as U.S. Patent Nos. 5,955,650 and 6,331,664.
  • Chitinases are endohydrolases that hydrolyze the ⁇ -1,4 bond between the N- acetylglucosamine residues of chitin, a component of the wall of many pathogenic fungi. Chitinases have been cloned from Arabidopsis, tobacco, bean, cucumber, tomato, and bacteria, and the sequences deposited in GenBank (see, for example, GenBank Accession No. A16119 for tobacco intracellular chitinase, ABO 15996 for chiA o ⁇ Serratia marcescens, GenBank Accession No. AB026636 for an Arabidopsis thaliana chitinase, and GenBank Accession No.
  • ⁇ -l,3-glucanases are a family of endohydrolases that degrade fragments of glucan, another component of the wall of pathogenic fungi.
  • ⁇ -l,3-glucanases have been cloned from Arabidopsis, pea, soybean, tobacco, bean, cucumber, tomato, rice, Hevea (para rubber), and bacteria. See GenBanlcAccession Nos. A16121, AB025632, AL353822, and D76437 for the nucleic acid and amino acid sequences of glucanases from tobacco, A.
  • PR5 proteins are thaumatin-like proteins that are part of the osmotin family of proteins.
  • Osmotins have an external surface with highly basic residues. Osmotins are thought to permeabilize the membrane surface of fungi, resulting in a modification of the pH gradient and destabilization of pressure gradients that maintain the tip of the hyphae in a tensed state. Consequently, cytoplasmic material is leaked and the hyphae rupture, or in the case of spores, the spores lyse.
  • Osmotin or osmotin-like polypeptides have been cloned from tobacco, soybean, carrot, cotton, potato, and bean.
  • GenBank Accession Nos. X65701, AL049500, and D76437 provide the nucleic acid and amino acid sequences of osmotin or osmotin-like proteins from tobacco, A. thaliana, and Nicotiana sylvestris. See also, U.S. Patent No. 6,087,161.
  • Endogenous PR1 proteins are highly induced during infection with pathogenic agents. PR1 proteins have been cloned from tobacco, Arabidopsis, and parsley. See GenBank Accession Nos.
  • AL031394, X12572, and AI352904 for the nucleic acid and amino acid sequences of PR1 proteins from A. thaliana, parsley, and R. napus, respectively. Decreasing expression of fad2 and/or fad6 alone or in combination with increasing the expression of one or more genes involved in fatty acid synthesis, or of host defense genes provides enhanced resistance to S. sclerotiorum and/or L. maculans in plants.
  • decreasing expression of fad2 and/or fad6 and increasing the expression of genes encoding PR5 and chitinase can provide enhanced resistance to blackleg in a transgenic plant relative to a control plant in which the expression of fad2 is not decreased and the amount of such polypeptides is not increased.
  • decreasing expression of fad2 and/or fad6 while increasing the expression of genes encoding chitinase, glucanase, and PR5 can provide enhanced resistance to S. sclerotiorum in a plant relative to a control plant.
  • Nucleic acid constructs suitable for use in the methods of the invention include nucleic acids encoding fad2 or fad6 operably linked to one or more regulatory elements such as a promoter.
  • constructs containing fad2 or fad6 constructs containing nucleic acids encoding proteins involved in fatty acid synthesis or host defense proteins can be used in the methods of the invention to enhance resistance to S. sclerotiorum and/or L. maculans. Standard molecular biology techniques can be used to generate nucleic acid constructs.
  • the expression of fad2 or fad6 can be decreased using co-suppression technology.
  • Co-suppression is a reduction in expression of a target gene upon introduction into a cell of a nucleic acid that is ultimately transcribed into an mRNA that has homo logy with the target gene's transcript. Therefore, co-suppression of fad2 or fad6 can be achieved using a construct that contains a fad2 or fad6 nucleic acid, respectively, operably linked in sense orientation to a regulatory element. It is not necessary that the fad2 or fad6 nucleic acid in the construct be full-length or have 100% homology with the target fad2 or fad6 nucleic acid, respectively, to be co-suppressed. See, for example, U.S. Patent Nos.
  • Expression of fad2 or fad6 also can be decreased using antisense technology.
  • the specific hybridization of a fad2 or fad6 antisense molecule with endogenous fad2 or fad6 nucleic acids, respectively, can interfere with the normal function of the endogenous nucleic acid.
  • antisense technology can disrupt replication and transcription.
  • antisense technology can disrupt, for example, translocation of the RNA to the site of protein translation, translation of protein from the RNA, splicing of the RNA to yield one or more mRNA species, and catalytic activity of the RNA.
  • Antisense technology can also facilitate nucleolytic degradation of an endogenous RNA. See, for example, Brantl, 2002, Biochim. Biophys. Acta, 1575:15-25 and Sazani et al., 2002, Curr. Opin. Botechnol, 13:468-72.
  • Antisense molecules can be directed at regions encompassing the translation initiation or termination codon of fad2 or fad6.
  • Antisense molecules also can be directed at the fad2 or fad6 open reading frame (ORF), at the 5' and 3' untranslated region of fad2 or fad6, and at intron regions and intron-exon junction regions.
  • ORF open reading frame
  • the effectiveness of an antisense molecule to decrease expression of fad2 or fad6 can be evaluated by measuring levels of the fad2 or fad6 mRNA or protein, respectively (e.g., by Northern blotting, RT- PCR, Western blotting, ELISA, or immunohistochemical staining).
  • hybridization means hydrogen bonding, wliich can be Watson-Crick, Hoogsteen, or reversed Hoogsteen hydrogen bonding, between complementary nucleotides. It is understood in the art that the sequence of a fad2 or fad6 antisense molecule need not be 100% complementary to that of its endogenous fad2 or fad6 nucleic acid, respectively, to be able to hybridize.
  • a fad2 or fad6 antisense molecule specifically hybridizes to an endogenous fad2 or fad6 nucleic acid, respectively, when (a) binding of the antisense molecule to the fad2 or fad6 DNA or RNA molecule, respectively, interferes with the normal function of the fad2 or fad6 DNA or RNA, respectively, and (b) there is sufficient complementarity to avoid non-specific binding of the antisense molecule to non-fad2 or non-fad6 sequences, respectively, under conditions in which specific binding is desired, i.e., under conditions in which in vitro assays are performed or under physiological conditions for in vivo assays.
  • RNA interference (RNAi) technology also can be used to decrease expression of fad2 or fad6.
  • RNAi technology utilizes constructs that produce aberrant RNA transcripts, which disrupt transcription and/or translation of the endogenous fad2 or fad6, respectively. See, for example, U.S. Patent No. 6,506,559; and PCT Publication Nos.
  • RNAi co-suppression construct can include a promoter, a fad2 or fad6 sequence operably linked to the promoter in sense orientation, a nucleic acid molecule encoding a self-splicing ribozyme operably linked to the fad2 or fad6 sequence, respectively, and a terminator sequence, operably linked to the self-splicing ribozyme nucleic acid.
  • the nucleic acid molecule encoding the self-splicing ribozyme can be the negative strand from the satellite RNA of Barley Yellow Dwarf Virus, for example.
  • an RNAi hairpin construct can contain a promoter, a region of the fad2 or fad6 sequence operably linked to the promoter in sense orientation, a spacer nucleic acid molecule operably linked to the sense fad2 or fad6 sequence, respectively, the complement of the same region of the fad2 or fad6 sequence, respectively, operably linked to the spacer nucleic acid in antisense orientation, and a terminator sequence operably linked to the antisense fad2 or fad6 sequence, respectively.
  • RNAi hairpin construct Following transcription of an RNAi hairpin construct, a double-stranded duplex RNA (e.g., a hairpin) is formed between the fad2 or fad6 complementary regions.
  • genes that produce proteins involved in fatty acid synthesis e.g., KASII, or thioesterases
  • host defense e.g., chitinase, ⁇ -l,3-glucanase, PR5, and/or PR1
  • an exogenous nucleic acid encoding a host defense protein can be operably linked to a regulatory element and introduced into a plant using transgenic methods such as those described herein.
  • the exogenous nucleic acid can be expressed to produce an amount of a host defense protein that is in addition to that produced by the endogenous nucleic acids.
  • an exogenous nucleic acid encoding a protein involved in fatty acid synthesis operably linked to a regulatory element can be introduced into a plant. Expression in plant tissue of such an exogenous nucleic acid can result in altered levels of particular fatty acids, thereby enhancing disease resistance. Altered levels of fatty acids in the plant tissue can be due to, for example, an increase in the amount of such protein (e.g., expression of an additional copy of a nucleic acid) or a decrease in the amount of such protein (e.g., by co-suppression of the exogenous nucleic acid).
  • regulatory elements typically do not themselves code for a gene product. Instead, regulatory elements affect the expression level of the coding sequence. Suitable regulatory elements include promoters and enhancers. Regulatory elements can be constitutive or inducible, and can be tissue specific (e.g., roots, seeds, veins, or the like) or developmental stage specific (e.g., Brassica developmental stages 1, 2, 3, 4, or 5). As used herein, “constitutive promoter” refers to a promoter that facilitates expression of a nucleic acid molecule without significant tissue- or temporal-specificity. An inducible promoter refers to a promoter that facilitates expression of a nucleic acid molecule in response to a stimulus such as a chemical, or light.
  • promoters are known (e.g., Weising et al., Ann. Rev. Genetics 22:421-478 (1988)). The following are representative examples of promoters suitable for use herein: regulatory sequences from fatty acid desaturase genes (e.g., Brassica fadlD or fad2F, see PCT Publication No.
  • WO 00/07430 alcohol dehydrogenase promoter from corn; light inducible promoters such as the ribulose bisphosphate carboxylase (Rubisco) small subunit gene promoters from a variety of species; major chlorophyll a/b binding protein gene promoters; the 19S or 35S promoters of cauliflower mosaic virus (CaMV); hsr203j promoter from tobacco (Pontier et al, 1994, Plant J., 5:507-21); as well as synthetic or other natural promoters that are either inducible or constitutive. See, e.g., U.S. Patent No. 6,087,560. Particularly useful are regulatory elements that facilitate expression in vegetative tissue(s) but result in little or no expression in seeds.
  • light inducible promoters such as the ribulose bisphosphate carboxylase (Rubisco) small subunit gene promoters from a variety of species; major chlorophyll a/b binding protein gene promoters; the 19S or 35S
  • Such regulatory elements can be operative in vegetative tissues such as leaves, both immature and mature, stems, or both leaves and stems. Such regulatory elements can confer constitutive expression in a vegetative tissue(s) or inducible expression in a vegetative tissue(s).
  • An example of a vegetative tissue-specific regulatory element is the FD rold promoter from Agrobacterium.
  • the regulatory element is a promoter of plastid gene expression.
  • Non-limiting examples of such a promoter include a 16S ribosomal RNA promoter, promoters of the photosynthetic genes rbcL and psbA, as well as the light- regulated promoter of the psbD operon. See, U.S. Patent No.
  • regulatory sequences are seed-specific, i.e., the particular gene product is preferentially expressed in developing seeds and expressed at low levels or not at all in the remaining tissues of the plant.
  • seed-specific promoters include napin, phaseolin, oleosin, and cruciferin promoters.
  • suitable regulatory sequences for expression of fad2, fad6, or host defense genes are known in the art. Promoters that result in expression of proteins in different tissues (e.g., stems vs. leaves) may be especially useful in different geographical regions. Sub-strains of L.
  • maculans having different degrees of virulence may be present in different regions of the world, e.g., PG3 strains in Europe and Australia may have different degrees of virulence compared to strains in other geographic regions.
  • the plant tissue in which fungal disease is most commonly observed may vary between different geographic regions.
  • promoters can be used that result in expression in those tissues.
  • Additional regulatory elements may be useful in the nucleic acid constructs of the present invention, including, but not limited to, polyadenylation sequences, translation control sequences (e.g., a ribosome binding site), enhancers, introns, and targeting sequences (i.e., a sequence targeting to a particular organelle, such as a plastid).
  • Such additional regulatory elements may not be necessary for sufficient expression of fad2 or fad6 nucleic acids, although they may increase expression by affecting transcription, stability of the mRNA, translational efficiency, or the like.
  • Such elements can be included in a nucleic acid construct as desired to obtain optimal expression of fad2 or fad6 nucleic acids, respectively, in the host cell(s).
  • An example of a nucleic acid construct encoding fad2 in sense orientation is shown in FIG. 1.
  • the 35S double enhancer promoter (35Sde) was cloned 5' of the fad2 sequences, and a Nos terminator was cloned into the construct 3' of the fad2 sequence.
  • One or more additional constructs can be generated that contain fad6 nucleic acids, or that contain genes encoding proteins involved in fatty acid synthesis or host defense. Nucleic acids encoding such proteins can be together on a single construct or each can be on a separate construct.
  • Decreasing expression offad2 and/or fad ⁇ Methods of enhancing disease resistance in a plant can be accomplished by decreasing expression of fad2 and/or fad6.
  • "decreasing expression” means a decrease in the transcription or translation of a fad2 or fad6 gene.
  • Expression of fad2 or fad6 can be decreased by mutagenesis, by transgenics, by combinations thereof, or by using existing germplasm. Mutagenesis Expression of fad2 and/or fad6 also can be decreased by mutagenesis.
  • Mutagenesis is the introduction of mutations into nucleic acids, either in vitro or in vivo. Mutations can be induced in living organisms or in cultured cells by a variety of mutagens, including ionizing radiation, ultraviolet radiation, or chemical mutagens, by infection with certain viruses which integrate into the host genome, or by the introduction of nucleic acids previously mutagenized in vitro.
  • mutagens including ionizing radiation, ultraviolet radiation, or chemical mutagens, by infection with certain viruses which integrate into the host genome, or by the introduction of nucleic acids previously mutagenized in vitro.
  • benzo[a]pyrene, N- acetoxy-2-acetylaminofluorene and aflatoxin Bl cause GC to TA transversions in bacteria and mammalian cells, although benzo[a]pyrene in particular can produce base substitutions such as AT to TA.
  • Plant cells from Brassica tissue can be mutagenized, for example, by exposing the cells to a chemical mutagen, and plants can be regenerated from such cells.
  • the plant cells or the regenerated plant can be screened for fatty acid content, particularly for the levels of oleic acid and linoleic acid, to identify fad2 or fad6 mutants.
  • a mutation can be introduced into a fad2 or fad6 nucleic acid molecule and introduced transgenically into a plant.
  • Transgenic cells and plants in which expression of fad2 or fad6 has been decreased can be obtained by introducing an appropriate nucleic acid construct (e.g., a co- suppression construct, an antisense construct, or an R ⁇ Ai construct as described above) into one or more plant cells and regenerating a plant.
  • a nucleic acid construct can be introduced into a plant cell by well-known transformation methods. Leaves, seeds, or other tissue can be analyzed to identify those plants containing the construct or having the desired level of expression of the construct. For example, the polymerase chain reaction (PCR) and/or Southern blotting can be used to determine if seeds or other tissue contains the nucleic acid construct.
  • PCR polymerase chain reaction
  • Southern blotting can be used to determine if seeds or other tissue contains the nucleic acid construct.
  • Plants used in the methods of the invention can be any dicotyledonous species, including, for example, Cruciferae plants such as Brassica spp. (both low erucic and high erucic acid rapeseed). Suitable Brassica species include R. napus, B. juncea, B. nigra, B. carinata, B. oleracea, and R. rapa. The Brassica variety designated Westar transformed with wild type fad2 (Westar/fad2) also can be used in the methods of the invention.
  • Cruciferae plants such as Brassica spp. (both low erucic and high erucic acid rapeseed).
  • Suitable Brassica species include R. napus, B. juncea, B. nigra, B. carinata, B. oleracea, and R. rapa.
  • the Brassica variety designated Westar transformed with wild type fad2 also can be used in the methods of the invention.
  • Transformation techniques for use in the invention include, without limitation, Agrobacterium-mediated transformation, polyethylene glycol treatment of protoplasts, electroporation, and particle gun transformation. Illustrative examples of transformation techniques are described in PCT Publication No. WO 99/43202 and U.S. Patent No. 5,204,253 (particle gun), and U.S. Patent No. 5,188,958 (Agrobacterium).
  • Transformation methods utilizing the Ti and Ri plasmids of Agrobacterium spp. typically use binary type vectors. Walkerpeach et al., in Plant Molecular Biology Manual, Gelvin & Schilperoort, eds., Kluwer Dordrecht, Cl:l-19 (1994). If cell or tissue cultures are used as the recipient tissue for transformation, plants can be regenerated from transformed cultures by techniques known to those skilled in the art. In addition, various plant species can be transformed using the pollen tube pathway technique. A plant described herein may be used as a parent to develop a plant line, or may itself be a member of a plant line, i.e., it is one of a group of plants that display little or no genetic variation between individuals for a particular trait.
  • Such lines can be created by several generations of self-pollination and selection for those species amenable to self- pollination. Vegetative propagation from a single parent using tissue or cell culture techniques also can be used. In some embodiments, cytoplasmic male sterility breeding systems are used to develop homozygous lines and also can be used to develop hybrids. Methods for producing hybrids can be found, for example, in U.S. Patent No. 6,323,392, and PCT Publication Nos. WO 92/05251 and WO 98/027806. i addition, Fick (1978, Agronomy, 19:279-337) and Vranceanu & Stoenescu (1971, Euphytica, 20:536-41) describe protocols for hybrid production in sunflower.
  • Transgenic plants can be entered into a breeding program, e.g., to increase seed, to introgress the novel construct(s) into other lines or species, or for further selection of other desirable traits. Desirable traits also can be fixed using di-haploid methods for screening and selecting embryos. Additional transgenic plants can be obtained by vegetative propagation of a single transgenic plant, for those species amenable to such techniques. Progeny of transgenic plants are included within the scope of the invention, provided that such progeny exhibit resistance to S. sclerotiorum and/or L. maculans.
  • Progeny of an instant plant include, for example, seeds formed on FI, F2, F3, and subsequent generation plants, or seeds formed on BC1, BC2, BC3, and subsequent generation plants. Seeds produced by a transgenic plant can be planted and the resulting plants can be bred or otherwise propagated (e.g., selfed) to obtain plants homozygous for the construct. Di-haploid plants exhibiting decreased expression of fad2 also are within the scope of the invention, and can be generated by methods known in the art.
  • a transgenic plant expressing fad2 or fad6 from a first nucleic acid construct can be crossed or mated with a second transgenic plant expressing a gene involved in fatty acid synthesis or host defense from a second nucleic acid construct to obtain plants having the desired combination of polypeptides and, thus, exhibiting the desired level of disease resistance.
  • Analyzing Plants Plants that have enhanced resistance to S. sclerotiorum and/or L. maculans can be identified by known techniques, including in vitro tests on plant tissue or field, growth chamber, or greenhouse tests. For S. sclerotiorum, tests for resistance can be performed by inoculating stems or detached leaves of plants with S.
  • sclerotiorum mycelium then evaluating any resulting necrosis (e.g., measuring length of necrosis) after a period of time sufficient for infection to develop.
  • Blackleg resistance can be evaluated, for example, by inoculating cotyledons or stems with L. maculans and measuring the length of necrosis or mean disease severity (MDS) after a period of time sufficient for infection to develop. MDS can be measured on a scale from 0 to 5, with 5 being the worst. Susceptible lines and highly resistant lines are used to obtain control values. For such inoculations and evaluations, it is desirable to use a substrain of L. maculans that is prevalent in the geographic region in which the resulting plants are to be utilized.
  • plants that have enhanced fungal resistance can be identified by an increased amount of oleic acid in leaf tissue from such plants.
  • the amount of oleic acid can constitute from about 10% to about 25% of the total fatty acid content of the leaf tissue, e.g., about 10% to about 20%, about 11% to about 20%o, about 12% to about 20%, about 13% to about 20%, about 14% to about 20%, about 12% to about 18%, or about 15% to about 18%.
  • plants that have enhanced fungal resistance can be identified by an increased ratio of oleic acid/linoleic acid in leaf tissue from such plants.
  • the ratio of oleic acid/linoleic acid can be from about 1.1 to about 5.0, e.g., about 1.1 to about 4.0, about 1.1 to about 4.0, about 1.2 to about 4.0, about 1.3 to about 4.0, about 1.4 to about 3.0, or about 1.5 to about 2.5.
  • plants that have enhanced fungal resistance can be identified by an increased amount of oleic acid in stem tissue from such plants.
  • the amount of oleic acid can constitute from about 20% to about 35% of the total fatty acid content of the stem tissue, e.g., about 20% to about 30%, about 21% to about 35%, about 22% to about 30%, about 23% to about 30%, about 24% to about 30%, about 22% to about 25%, or about 15% to about 25%.
  • a phenotype is considered enhanced when the phenotype of a particular cell, plant, plant line, or plant population is statistically significantly different from a corresponding cell, plant, plant line, or plant population that is a suitable control, at ap ⁇ 0.05 with an appropriate parametric or non-parametric statistic.
  • a suitable parametric or non-parametric statistic includes a Chi-square test, a Student's t-test, a Mann- Whitney test, or an F-test.
  • a difference in phenotype is statistically significant at y? ⁇ 0.01, p ⁇ 0.005, orp ⁇ 0.001.
  • plants that have enhanced fungal resistance can be identified by in vitro analysis of protein expression levels, evaluation of in vitro resistance in plant tissue, and/or in vivo resistance of whole plants in the field.
  • Additional Resistance Factors In addition to the methods described above for decreasing expression of fad2 and/or fad6 using transgenic techniques or mutagenesis, expression of one or more host defense genes (exogenous or endogenous) can be induced by compounds such as salicylic acid, jasmonic acid, and ethylene to further enhance resistance.
  • Salicylic acid, jasmonic acid, and ethylene are endogenous signal molecules that have been implicated in plant defense signaling pathways against pathogen infection. Salicylic acid levels increase locally and systematically in plant tissue following pathogen infection, and exogenous application of salicylic acid results in enhanced resistance to a broad range of pathogens.
  • salicylic acid is required for the rapid localized activation of the expression of defense response genes to produce, for example, PR proteins.
  • Salicylic acid also induced systemic expression of defense response genes to produce, for example, PR proteins, which results in systemic acquired resistance.
  • An extensive review of the role of salicylic acid in plant disease resistance can be found in Dempsey et al. (1999, Crit. Rev. Plant Sci., 18:547-75).
  • Jasmonic acid a fatty-acid-derived signaling molecule
  • Jasmonic acid and/or ethylene can induce the production of several PR proteins, including Plant Defensinl.2 (PDF1.2), Thionin2.1 (THI2.1), Hevein-Like proteins (HEL) and ChitinaseB (CHIB).
  • PDF1.2 Plant Defensinl.2
  • TKI2.1 Thionin2.1
  • HEL Hevein-Like proteins
  • CHIB ChitinaseB
  • plants in which the expression of fad2 and/or fad6 is decreased can be treated with one or more of the above-indicated compounds to increase expression of genes involved in host defense, thereby further enhancing the resistance to S. sclerotiorum and/or L. maculans.
  • nucleic acids encoding enzymes involved in the biosynthesis of such signaling molecules can be introduced into plants using the methods and materials described above to increase the amount of salicylic acid in the plant and thereby increase expression of genes involved in host defense. See, for example, Verberne et al, 2000, Nat. Biotech., 18:779-83, and Yalpani et al., 2001, The Plant Cell, 13:1401-9.
  • the invention will be further described in the following examples, which do not limit the scope of the invention described in the claims.
  • Example 1 Materials and Methods Plant Lines Westar variety is wild type for both fad2D and fad2F.
  • the IMC 129 variety contains a point mutation in fad2D.
  • the Q508 and 5Q4275 lines were derived from IMC 129 (i.e., both lines contain the point mutation in fad2D) and each contains a different point mutation in fad2F.
  • Q508/fad2 is the Q508 line transformed with wild type fad2D under control of the 35S double enhancer promoter (35Sde) (see, for example, Li et al., 2001, Plant Sci., 160:877-87 and references therein).
  • 35Sde 35S double enhancer promoter
  • sclerotiorum mycelial implant (7 mm in diameter) was deposited at the tip of the leaf and the dishes were kept at 16°C in an air-conditioned room. Humidity was maintained by wrapping the plates in plastic bags. The length of necrosis (in cm) along the midrib of the tested leaf was measured four days later and compared to the length of necrosis on a control (Westar) leaf.
  • Mycelial implants were prepared by growing the fungus on agar-containing water for four days then sub-culturing onto potato dextrose agar (PDA) medium for three days. For every line, at least 4 sets of 5 plants were evaluated using one leaf from each plant (Table II).
  • the Williams test (phoma test on cotyledons) was performed on the Westar (a susceptible control), IMC129, Q508, 5Q4275, Q508/fad2, and Bisd (a spring B. napus line that is resistant to the PG3 strain of L. maculans) lines, to evaluate blackleg resistance. See Williams & Delwiche, 1979 Cruciferae Conference, Eucarpia, 1980, page 164. Nine plants per line were evaluated for blackleg resistance. The rape plants were sown in a flat containing a greenhouse soil mixture and maintained at 25 °C until the test was ready to be performed. The plants were watered and fertilized.
  • Young leaves were systematically removed up to the day of the inoculation, which was 10 days after sowing. A small hole was made in each cotyledon lobe before inoculation and 10 ⁇ l of a suspension of pycnidiospores (500,000 spores/ml) were deposited in each hole. The flats were placed in cloches for two days. Necrosis diameter was measured two weeks later. The blackleg test on stem was performed on 1 month-old plants. A hole was created in the stem at about 8 cm from the bottom of the plant. Ten ⁇ l of a suspension of pregerminated pycnidiospores (500,000 spores/ml) were deposited in each hole. Pycnidiospores were obtained by growing the L.
  • Pregerminated pycnidiospores were made by adding glucose to the spore suspension at a final concentration of 10 mM. The spores were then pre-germinated for 3 days at room temperature. The wound was then covered by an adhesive bandage onto which 15 ⁇ l of the spore suspension had been applied. The plants were kept at least 80% humidity for at least the first 4 days after inoculation. The scoring was performed one month after inoculation by measuring the length of necrosis on the stem.
  • GC conditions were as follows: Column: 5 m x 0.32 mm DB-Wax (0.5 ⁇ m film thickness); Detector: FID; Inlet temperature: 250°C; Detector temperature: 250°C; Split ratio: 100:1; Carrier gas: helium at 30.0 ml/min; and Oven program: 1.0 min at 220°C; 10.0°C/min to 245°C; 3.0 min at 245°C.
  • pMBl 19 Construct A full-length oleoyl-fatty acid desaturase isoform "D" (fad2D) was amplified from Brassica napus genomic DNA (Westar variety) by PCR using primers Fad2D-Exp5' having the sequence: 5'-cau cau cau cau aaa aaac aac cat ggg tgc agg tgg aag aat-3' (SEQ ID NO:l) and Fad2D-Exp3' having the sequence: 5'-acu acu acu acu gtc gac ata gaa gag aaa ggt tea g-3' (SEQ ID NO:2).
  • the amplified DNA was ligated into the pAMPl vector (GIBCO). Subsequently, both strands of the fad2D gene was sequenced to confirm fidelity, and then released with Sail digestion. The Sail fragment containing the fad2D gene was cloned 3' to the 35Sde promoter at the Sail site in the pl079 vector. Next, the DNA region containing the 35Sde-fad2D-Nos terminator cassette was released from pl079 by Hindlll and subcloned at the Hindlll site in pBI121 (Clontech, Palo Alto, CA), thereby generating pMBl 19.
  • Figure 1 shows a schematic of pMBl 19.
  • the Q508 line contains a point mutation in the fad2D gene and another different point mutation in the fad2F gene. This line was transformed with the pMBl 19 binary construct using the - -tgrob ⁇ cte ⁇ ' wm-mediated transformation method. Transgenic plants were evaluated for their fatty acid composition (Table I). Results confirmed that the wild type fad2D gene was able to complement the fad2 mutation in Q508. Table I. Leaf Fatty Acid Composition of Canola Lines
  • Example 2 Non-Transgenic Approach To Enhancing Resistance To Sclerotinia in Brassica IMC 129 plants were similar to Westar plants in their resistance to S. sclerotiorum infection based on the detached leaf assay (Table II, Table III).
  • Q508 and 5Q4275 lines displayed enhanced resistance to S. sclerotiorum infection in detached leaves (Table II, Table III).
  • the resistance of fad2D and fad2F genes are directly responsible for the enhanced plant resistance to S. sclerotiorum, the resistance of
  • Q508/fad2 to Sclerotinia infection was examined.
  • Q508/fad2 plants show normal root growth at low temperatures, and the fatty acid compositions of their seeds, roots, and leaves are similar to that of the Westar variety.
  • Q508/fad2 plants, similar to Westar variety did not display enhanced resistance to S. sclerotiorum infection in leaves (Table II, Table III). Therefore, the fad2 mutations in Q508 plant are directly responsible for the enhanced resistance to S. sclerotiorum infection in leaves.
  • fad2 mutations directly influence the cytosolic levels of 18:1, 18:2, and 18:3 fatty acids in plant tissues. Thus, the observed plant resistance to S.
  • sclerotiorum in leaves is linked to the altered levels of these fatty acids. The most significant change is in the 18:1 and 18:2 fatty acid levels and their ratio. See Table IV. The high levels of 18 : 1 fatty acid and the low levels of 18:2 fatty acid in Q508 and 5Q4275 canola lines correlate with enhanced disease resistance to S. sclerotiorum infection in leaves (Table II, Table III). Conversely, the low levels of 18:1 fatty acid and high levels of 18:2 fatty acid in IMC 129 and Q508/fad2 correlate with a level of S. sclerotiorum resistance in leaves that is similar to the resistance exhibited by the Westar variety (Table II, Table III).
  • Example 3 Transgenic Approach To Enhancing Resistance To Sclerotinia in Brassica Canola tissue (Westar variety) was transformed with a construct containing fad2 in sense orientation under control of the Cruciferin promoter, a Brassica napus seed specific promoter, and regenerated into plants (Westar/fad2). Seeds from Westar/fad2 exhibited co-suppressed fad2 expression as evidenced by the following.
  • the 18:1 and 18:2 fatty acid level in the seeds from Westar/fad2 plants was 85% and 2% of total fatty acid content, respectively.
  • Westar/fad2 plants when compared to Westar variety, Westar/fad2 plants also showed an increase in 18:1 content from about 1.5% in Westar leaves to about 15% in Westar/fad2 leaves, and a decrease in 18:2 content from about 13% in Westar leaves to about 8% in Westar/fad2 leaves (Table V).
  • Westar/fad2 plants also exhibited enhanced resistance to S. sclerotiorum similar to that exhibited by the Q508 line (Table II, Table VI).
  • Example 4 Non-Transgenic Approach To Enhancing Resistance To Blackleg in Brassica
  • Example 2 describes the creation of several canola lines with mutations in fad2 genes, and their fatty acid composition in leaves and seeds. These lines were also tested for their resistance to L. maculans pathogen, the causal agent of Blackleg disease using the cotyledon assay. Plants with enhanced resistance to S. sclerotiorum infection (Table II) were also slightly more resistant to L. maculans infection (Table VII).
  • a l 1 mm lesion
  • 2 3 mm lesion
  • 3 6 mm lesion
  • 4 10 mm lesion
  • Example 5 Transgenic Approach To Enhancing Resistance To Blackleg in Brassica
  • Example 3 describes the development of Westar/fad2 transgenic plants.
  • Westar/fad2 plants also were tested for resistance to L. maculans, the causal agent of blackleg, using the stem assay.
  • the 18:1 and 18:2 fatty acid levels in Westar/fad2 seeds was 85% and 2% of total fatty acid content, respectively.
  • Westar/fad2 plants showed an increase in 18:1 content of about 6.3% in Westar stems to about 26.4% in Westar/fad2 stems, and a decrease in 18:2 content from about 17.5% in Westar stems to about 7.6% in Westar/fad2 stems (Table VIII).
  • Example 6 Transgenic Approach to Enhancing Resistance to Sclerotinia in Sunflower Sunflower (Helianthus annuus) lines are available that exhibit high oleic acid in the seeds (see, for example, Sperling et al., 1990, 2 Naturforsch, 45:166-72).
  • the lines that exhibit high oleic acid in the seeds exhibit an oleic acid content in the leaves that is similar to wild type sunflower (see Table X and, for example, Sperling et al., 1990, .
  • sunflower plants are transformed with a binary construct containing a fad2 nucleic acid under control of the ribulose 1,5-bisphosphate carboxylase (rbcS) promoter using a protocol involving a combination of particle bombardment followed by Agrobacterium-mediaXed transformation (Bidney et al., 1992, Plant Mol. Biol., 18:301- 13, and Malone-Schoneberg et al., 1994, Plant Sci., 103:199-207). The resulting plants are analyzed for fatty acid composition as described in Example 1, and compared with the fatty acid composition of wild type sunflower (Table X).
  • rbcS ribulose 1,5-bisphosphate carboxylase
  • Example 7 Transgenic Approach to Enhancing Resistance to Sclerotinia in Soybean Soybean (Glycine max) plants are transformed with a binary construct containing a fad2 nucleic acid coding region under control of the rbcS promoter using
  • Example 1 Those plants exhibiting an increase in 18:1 and a decrease in 18:2 levels are evaluated for their resistance to infection by Sclerotinia as described in Example 1.
  • Sclerotinia resistance in the transgenic soybean plants is compared to the Sclerotinia resistance exhibited by the wild type soybean plants.
  • Example 8 Non-transgenic Approach to Enhancing Resistance to Sclerotinia in Sunflower or Soybean Mutagenesis, for example, can be used to enhance resistance to Sclerotinia in sunflower or soybean.
  • Mutagenesis of sunflower or soybean is performed essentially as described in U.S. Patent No. 5,668,299 or WO 92/03919.
  • the resulting plants are analyzed for fatty acid composition as described in Example 1, and compared with the fatty acid composition of wild type sunflower (Table X) or wild type soybean. Those plants exhibiting an increase in 18:1 and a decrease in 18:2 levels are evaluated for their resistance to infection by Sclerotinia as described in Example 1.
  • Sclerotinia resistance in the mutagenized sunflower or soybean plants is compared to Sclerotinia resistance in wild type sunflower or soybean plants.
  • Example 9 High Oleic Dihaploid Lines and Sclerotinia Resistance Leaves were detached from a number of different high-oleic dihaploid canola lines at a time when the plants were flowering and treated with Sclerotinia as described in Example 1.
  • the dihaploid canola lines were generated by crossing a high oleic canola line (-85%) with a canola line containing typical levels of oleic acid (-55-60%), and flowers from the FI plants were made dihaploid using colchicines. Experiments were repeated four times with two pathological tests each. The sizes of the resulting necrotic lesions were measured in millimeters (mm) (Table XI).

Landscapes

  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • General Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Plant Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Nutrition Science (AREA)
  • Breeding Of Plants And Reproduction By Means Of Culturing (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

L'invention concerne des méthodes de production de plantes qui présentent une meilleure résistance à Sclerotinia sclerotiorum et/ou Leptosphaeria maculans.
PCT/US2004/017029 2003-05-30 2004-05-28 Methodes de production de plantes qui presentent une meilleure resistance aux maladies WO2005000007A2 (fr)

Priority Applications (4)

Application Number Priority Date Filing Date Title
CA002530566A CA2530566A1 (fr) 2003-05-30 2004-05-28 Methodes de production de plantes qui presentent une meilleure resistance aux maladies
AU2004251638A AU2004251638A1 (en) 2003-05-30 2004-05-28 Methods of making plants that exhibit enhanced disease resistance
EP04753784A EP1633867A4 (fr) 2003-05-30 2004-05-28 Methodes de production de plantes qui presentent une meilleure resistance aux maladies
AU2010202889A AU2010202889A1 (en) 2003-05-30 2010-07-08 Methods of making plants that exhibit enhanced disease resistance

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US47448203P 2003-05-30 2003-05-30
US60/474,482 2003-05-30

Publications (2)

Publication Number Publication Date
WO2005000007A2 true WO2005000007A2 (fr) 2005-01-06
WO2005000007A3 WO2005000007A3 (fr) 2006-01-12

Family

ID=33551496

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2004/017029 WO2005000007A2 (fr) 2003-05-30 2004-05-28 Methodes de production de plantes qui presentent une meilleure resistance aux maladies

Country Status (4)

Country Link
EP (1) EP1633867A4 (fr)
AU (2) AU2004251638A1 (fr)
CA (1) CA2530566A1 (fr)
WO (1) WO2005000007A2 (fr)

Cited By (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006135717A1 (fr) * 2005-06-09 2006-12-21 Pioneer Hi-Bred International, Inc. Brassica resistant a la sclerotinia et procede d'induction de la resistance contre la sclerotinia
CN100346785C (zh) * 2001-10-25 2007-11-07 迪内希尚蒂拉尔·帕特尔 选择性环氧化酶ⅱ抑制剂的新型制剂
WO2012059497A1 (fr) 2010-11-02 2012-05-10 Bayer Cropscience Ag N-hétarylméthyl pyrazolylcarboxamides
WO2012089757A1 (fr) 2010-12-29 2012-07-05 Bayer Cropscience Ag Dérivés d'hydroxymoyl-tétrazole fongicides
US8722072B2 (en) 2010-01-22 2014-05-13 Bayer Intellectual Property Gmbh Acaricidal and/or insecticidal active ingredient combinations
US9206137B2 (en) 2010-11-15 2015-12-08 Bayer Intellectual Property Gmbh N-Aryl pyrazole(thio)carboxamides
US9265252B2 (en) 2011-08-10 2016-02-23 Bayer Intellectual Property Gmbh Active compound combinations comprising specific tetramic acid derivatives
WO2017191580A1 (fr) * 2016-05-03 2017-11-09 University Of Manitoba Plantes et procédés pour lutter contre des pathogènes fongiques des plantes

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0668919B1 (fr) * 1992-11-17 2003-06-04 E.I. Du Pont De Nemours And Company Genes pour des desaturases d'acides gras en position delta-12 microsomales et enzymes apparentees provenant de plantes
JP4209949B2 (ja) * 1997-06-12 2009-01-14 カーギル，インコーポレーテッド 脂肪酸デサチュラーゼおよびその変異配列
US6166291A (en) * 1997-07-18 2000-12-26 Pioneer Hi-Bred International, Inc. Production of pathogen resistant plants
JP2001320993A (ja) * 1998-10-02 2001-11-20 Atsushi Iba 高温耐性植物
US6864362B2 (en) * 2000-03-16 2005-03-08 E. I. Du Pont De Nemours And Company Hypoallergenic transgenic soybeans
WO2002061043A2 (fr) * 2001-01-29 2002-08-08 Cargill, Incorporated Plantes transgeniques resistant aux champignons

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See references of EP1633867A4 *

Cited By (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN100346785C (zh) * 2001-10-25 2007-11-07 迪内希尚蒂拉尔·帕特尔 选择性环氧化酶ⅱ抑制剂的新型制剂
US8263827B2 (en) 2005-06-09 2012-09-11 Pioneer Hi Bred International Inc Sclerotinia-resistant Brassica
US8558067B2 (en) 2005-06-09 2013-10-15 Pioneer Hi-Bred International, Inc. Sclerotinia-resistant brassica
WO2006135717A1 (fr) * 2005-06-09 2006-12-21 Pioneer Hi-Bred International, Inc. Brassica resistant a la sclerotinia et procede d'induction de la resistance contre la sclerotinia
US7977537B2 (en) 2005-06-09 2011-07-12 Pioneer Hi Bred International Inc Sclerotinia-resistant brassica
US7977538B2 (en) 2005-06-09 2011-07-12 Pioneer Hi Bred International Inc Sclerotinia-resistant Brassica
US7977540B2 (en) 2005-06-09 2011-07-12 Pioneer Hi Bred International Inc Sclerotinia-resistant Brassica
US7982100B2 (en) 2005-06-09 2011-07-19 Pioneer Hi Bred International Inc Sclerotinia-resistant Brassica
US7982101B2 (en) 2005-06-09 2011-07-19 Pioneer Hi Bred International Inc Sclerotinia-resistant Brassica
US7985893B2 (en) 2005-06-09 2011-07-26 Pioneer Hi Bred International Inc Sclerotinia-resistant Brassica
CN101243188B (zh) * 2005-06-09 2013-07-24 先锋高级育种国际公司 抗核盘菌芸苔及开发抗核盘菌的方法
US7977539B2 (en) 2005-06-09 2011-07-12 Pioneer Hi Bred International Inc Sclerotinia-resistant Brassica
US7939722B2 (en) 2005-06-09 2011-05-10 Pioneer Hi-Bred International, Inc. Sclerotinia-resistant Brassica and methods for development of resistance to Sclerotinia
US8558066B2 (en) 2005-06-09 2013-10-15 Pioneer Hi-Bred International, Inc. Sclerotinia-resistant Brassica
EA018509B1 (ru) * 2005-06-09 2013-08-30 Пайонир Хай-Бред Интернэшнл, Инк. Потомство и семя растения brassica, устойчивого к sclerotinia, и их применение для получения масла или муки
US8558068B2 (en) 2005-06-09 2013-10-15 Pioneer Hi-Bred International, Inc. Sclerotinia-resistant Brassica
US8722072B2 (en) 2010-01-22 2014-05-13 Bayer Intellectual Property Gmbh Acaricidal and/or insecticidal active ingredient combinations
WO2012059497A1 (fr) 2010-11-02 2012-05-10 Bayer Cropscience Ag N-hétarylméthyl pyrazolylcarboxamides
US9206137B2 (en) 2010-11-15 2015-12-08 Bayer Intellectual Property Gmbh N-Aryl pyrazole(thio)carboxamides
WO2012089757A1 (fr) 2010-12-29 2012-07-05 Bayer Cropscience Ag Dérivés d'hydroxymoyl-tétrazole fongicides
US9265252B2 (en) 2011-08-10 2016-02-23 Bayer Intellectual Property Gmbh Active compound combinations comprising specific tetramic acid derivatives
US11085052B2 (en) 2016-05-03 2021-08-10 University Of Manitoba Plants and methods for controlling fungal plant pathogens
WO2017191580A1 (fr) * 2016-05-03 2017-11-09 University Of Manitoba Plantes et procédés pour lutter contre des pathogènes fongiques des plantes
CN109640632A (zh) * 2016-05-03 2019-04-16 马尼托巴大学 用于控制真菌植物病原体的植物和方法

Also Published As

Publication number Publication date
EP1633867A4 (fr) 2007-09-26
CA2530566A1 (fr) 2005-01-06
WO2005000007A3 (fr) 2006-01-12
EP1633867A2 (fr) 2006-03-15
AU2004251638A1 (en) 2005-01-06
AU2010202889A1 (en) 2010-07-29

Similar Documents

Publication Publication Date Title
AU2010202889A1 (en) Methods of making plants that exhibit enhanced disease resistance
RU2667424C2 (ru) Способы и композиции для избирательной регуляции экспрессии белка
Liu et al. Differential expression pattern of an acidic 9/13-lipoxygenase in flower opening and senescence and in leaf response to phloem feeders in the tea plant
US20070150982A1 (en) Fungal Resistant Transgenic Plants
US5474925A (en) Immobilized proteins in cotton fiber
EP1859044B1 (fr) Résistence contre les mauvaises herbes
CA2332643A1 (fr) Adn codant acetyle coa carboxylase de l'avoine
Xing et al. Modification of fatty acids in eggplant affects its resistance to Verticilliumdahliae
Tsitsigiannis et al. Aspergillus infection inhibits the expression of peanut 13 S-HPODE-forming seed lipoxygenases
RU2639517C2 (ru) Энхансер палочковидного вируса сахарного тростника (scbv) и его применение в функциональной геномике растений
Rajasekaran et al. Inhibition of fungal growth in planta and in vitro by transgenic tobacco expressing a bacterial nonheme chloroperoxidase gene
WO2008089061A2 (fr) Sorgho résistant aux herbicides inhibiteurs de l'acetyl-coa carboxylase
US20090313718A1 (en) Polynucleotides encoding caryophyllene synthase and uses thereof
WO2009100433A1 (fr) Procédés et compositions pour la lutte contre les parasites des plantes
US20210010014A1 (en) Peanut with reduced allergen levels
Irsyadi et al. Molecular and phenotypic characteristics of T1 transgenic yellow cosmos (Cosmos sulphureus) carrying neomycin phosphotransferase II gene
AU2011354577B2 (en) Composition containing gene encoding ABC transporter proteins for increasing size of plant seed and content of fat stored within seed
US20040205842A1 (en) Lipoxygenase overexpression in plants and reduction in plant sensitivity to diseases and to attacks from pathogenic organisms
JP2000512503A (ja) 植物におけるオゾン誘導性遺伝子発現
WO2023041987A1 (fr) Protéines pin6 pour la formation de structures de type nodule
AU2002240140A1 (en) Fungal resistant transgenic plants
Kocsy et al. Transformation of soybean and use of transgenic lines in basic and applied research
Folta Soybean seed trait improvements and their effects on human and animal nutrition
Savory Developing disease resistance in Colocasia esculenta L. Schott through Agrobacterium tumefasciens-mediated transformation with a stilbene synthase gene, vst1
ARABIDOPSIS existing message are suspended resulting in steady-state message level throughout the chilling interval.

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NA NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GM KE LS MW MZ NA SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LU MC NL PL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
ENP Entry into the national phase in:

Ref document number: 2530566

Country of ref document: CA

WWE Wipo information: entry into national phase

Ref document number: 2004251638

Country of ref document: AU

WWE Wipo information: entry into national phase

Ref document number: 2004753784

Country of ref document: EP

ENP Entry into the national phase in:

Ref document number: 2004251638

Country of ref document: AU

Date of ref document: 20040528

Kind code of ref document: A

WWP Wipo information: published in national office

Ref document number: 2004251638

Country of ref document: AU

DPEN Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed from 20040101)
WWP Wipo information: published in national office

Ref document number: 2004753784

Country of ref document: EP